Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Celalettin Eroglu"'
Autor:
Mutlay Sayan, Mehmet Fuat Eren, Sarah Sabrine Kilic, Ayse Kotek, Sedenay Oskeroglu Kaplan, Ozge Duran, Funda Cukurcayır, Ibrahim Babalıoglu, Ozlem Derinalp Or, Gul Aysen Ozturk, Celalettin Eroglu, Fatma Teke, Neslihan Kurtul, Tugce Kutuk, Beyhan Ceylaner Bicakci, Sukran Senyurek, Meryem Aktan, Swati Mamidanna, Nisha Ohri, Bruce Haffty, Banu Atalar
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background Access to cancer care is a problem that continues to plague refugees displaced from their home countries. The turbulent political crisis in Syria, which has led to millions of refugees seeking asylum in Turkey, merits further atte
Externí odkaz:
https://doaj.org/article/0e7c4b852a204d45aae4d5d71391cc78
Publikováno v:
Brazilian Journal of Otorhinolaryngology, Vol 86, Iss 6, Pp 676-686 (2020)
Introduction: Three-weekly cisplatin dose is accepted for standard treatment for concurrent chemo-radiotherapy in nasopharyngeal carcinoma. However, different chemotherapy schedules are presented in the literature. Objective: We intend to compare tox
Externí odkaz:
https://doaj.org/article/2faa911234394349a2976f3970c20849
Autor:
Celalettin Eroglu, Okan Orhan, Dilek Unal, Gamze G Dogu, Halit Karaca, Mustafa Dikilitas, Ahmet Oztürk, Metin Ozkan, Bünyamin Kaplan
Publikováno v:
Annals of Thoracic Medicine, Vol 8, Iss 2, Pp 109-115 (2013)
Objectives: To evaluate treatment results and toxicities in patients who received concomitant chemoradiotherapy (CRT) followed by consolidation with docetaxel and cisplatin in locally advanced unresectable non-small cell lung cancer (NSCLC). Methods:
Externí odkaz:
https://doaj.org/article/c1d3e0d61b5b446096cbb70276ee92e2
Autor:
Muzaffer Keklik, Leylagul Kaynar, Afra Yildirim, Serdar Sivgin, Celalettin Eroglu, Serife Cingoz, Cigdem Pala, Bulent Eser, Mustafa Cetin, Ali Unal
Publikováno v:
Case Reports in Hematology, Vol 2013 (2013)
Total body irradiation (TBI) combined with chemotherapy is widely used as a pretreatment regimen of bone marrow transplantation (BMT) in hematologic disorders. Late complications related to TBI as part of the conditioning regimen for hematopoietic st
Externí odkaz:
https://doaj.org/article/069ad0a66b3f42fb988c22732ae0e9d2
Autor:
Muzaffer Keklik, Serdar Sivgin, Cigdem Pala, Celalettin Eroglu, Gulsah Akyol, Leylagul Kaynar, Mustafa Yavuz Koker, Demet Camlica, Ali Unal, Mustafa Cetin, Bulent Eser
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 4, Iss 1, Pp e2012063-e2012063 (2012)
Multiple myeloma is a malignant proliferation of plasma cells that mainly affects bone marrow. Pleural effusions secondary to pleural myelomatous involvement have rarely been reported in the literature. As it is rarely detected, we aimed to report a
Externí odkaz:
https://doaj.org/article/ef3e83b1ce6349ea94c9e507b8fa27a2
Autor:
Mutlay Sayan, Mehmet Fuat Eren, Ayse Kotek, Sedenay Oskeroglu Kaplan, Ozge Duran, Funda Cukurcayır, Ibrahim Babalıoglu, Ozlem Derinalp Or, Gul Aysen Ozturk, Celalettin Eroglu, Fatma Teke, Neslihan Kurtul, Tugce Kutuk, Beyhan Ceylaner Bicakci, Sukran Senyurek, Meryem Aktan, Swati Mamidanna, Nisha Ohri, Bruce Haffty, Banu Atalar
Publikováno v:
SSRN Electronic Journal.
BackgroundAccess to cancer care is a problem that continues to plague refugees displaced from their home countries. The turbulent political crisis in Syria, which has led to millions of refugees seeking asylum in Turkey, merits further attention. We
Publikováno v:
Brazilian Journal of Otorhinolaryngology, Volume: 86, Issue: 6, Pages: 676-686, Published: 11 DEC 2020
Brazilian Journal of Otorhinolaryngology v.86 n.6 2020
Brazilian Journal of Otorhinolaryngology
Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF)
instacron:ABORL-CCF
Brazilian Journal of Otorhinolaryngology, Vol 86, Iss 6, Pp 676-686 (2020)
Brazilian Journal of Otorhinolaryngology v.86 n.6 2020
Brazilian Journal of Otorhinolaryngology
Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF)
instacron:ABORL-CCF
Brazilian Journal of Otorhinolaryngology, Vol 86, Iss 6, Pp 676-686 (2020)
Introduction: Three-weekly cisplatin dose is accepted for standard treatment for concurrent chemo-radiotherapy in nasopharyngeal carcinoma. However, different chemotherapy schedules are presented in the literature. Objective: We intend to compare tox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afed26f020e3145adc01054993fe04c1
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1808-86942020000600676&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1808-86942020000600676&lng=en&tlng=en
Autor:
Sedenay Oskeroglu Kaplan, Beyhan Ceylaner Bicakci, Neslihan Kurtul, Ayse Kotek, Funda Cukurcayir, Ozlem Derinalp Or, Tugce Kutuk, Fatma Teke, Gul Aysen Ozturk, Mutlay Sayan, Celalettin Eroglu, Nisha Ohri, Mehmet Fuat Eren, Ozge Duran, Banu Atalar, Meryem Aktan, Ibrahim Babalioglu, Swati Mamidanna, Sukran Senyurek, Bruce G. Haffty
Publikováno v:
Radiotherapy and Oncology. 152:S684-S685
Autor:
Tuba Dilay Unal, Sedat Çağlı, Deniz Avcı, Aslihan Kiraz, Ibrahim Ozcan, Bünyamin Kaplan, Celalettin Eroglu, İmdat Yüce, Arzu Tasdemir, Dilek Unal
Publikováno v:
International Journal of Radiation Biology. 92:364-370
To evaluate cytogenetic damage of radiotherapy (RT) and chemoradiotherapy (CRT) in long-term head and neck cancer survivors.This study included 20 patients treated with RT (10 patients) or CRT (10 patients) for head and neck cancer. Nine healthy volu
Autor:
Celalettin Eroglu, Selahattin Mentes, Bulent Eser, Fatih Kurnaz, Okan Orhan, Dicle Aslan, Serdar Sivgin, Serdar Soyuer, Ali Ünal, Muzaffer Keklik, Mustafa Cetin, Cem Sahin, Leylagül Kaynar, Oğuz Galip Yildiz
Publikováno v:
American Journal of Clinical Oncology. 38:68-73
OBJECTIVES To assess the outcomes of overall survival and posttransplantation survival in patients with Hodgkin lymphoma (HL) undergoing autologous stem cell transplantation (ASCT) because of the development of relapse or resistance after chemotherap